JP6034292B2 - ドライウエイト予測装置 - Google Patents
ドライウエイト予測装置 Download PDFInfo
- Publication number
- JP6034292B2 JP6034292B2 JP2013533964A JP2013533964A JP6034292B2 JP 6034292 B2 JP6034292 B2 JP 6034292B2 JP 2013533964 A JP2013533964 A JP 2013533964A JP 2013533964 A JP2013533964 A JP 2013533964A JP 6034292 B2 JP6034292 B2 JP 6034292B2
- Authority
- JP
- Japan
- Prior art keywords
- value
- individual
- calf
- dry weight
- normalized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 claims description 134
- 244000309466 calf Species 0.000 claims description 84
- 238000005259 measurement Methods 0.000 claims description 57
- 210000003722 extracellular fluid Anatomy 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 21
- 238000000691 measurement method Methods 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 9
- 238000004590 computer program Methods 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 42
- 238000000502 dialysis Methods 0.000 description 41
- 238000011282 treatment Methods 0.000 description 35
- 238000013459 approach Methods 0.000 description 28
- 239000003795 chemical substances by application Substances 0.000 description 14
- 230000036571 hydration Effects 0.000 description 13
- 238000006703 hydration reaction Methods 0.000 description 13
- 238000010586 diagram Methods 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 9
- 230000037213 diet Effects 0.000 description 9
- 239000002934 diuretic Substances 0.000 description 9
- 230000037396 body weight Effects 0.000 description 7
- 230000001882 diuretic effect Effects 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 229940127291 Calcium channel antagonist Drugs 0.000 description 6
- 206010019280 Heart failures Diseases 0.000 description 6
- 239000000480 calcium channel blocker Substances 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000001631 haemodialysis Methods 0.000 description 5
- 230000000322 hemodialysis Effects 0.000 description 5
- 208000017169 kidney disease Diseases 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010019663 Hepatic failure Diseases 0.000 description 4
- 208000002720 Malnutrition Diseases 0.000 description 4
- 206010047249 Venous thrombosis Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 208000020832 chronic kidney disease Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000009499 grossing Methods 0.000 description 4
- 208000007903 liver failure Diseases 0.000 description 4
- 231100000835 liver failure Toxicity 0.000 description 4
- 235000000824 malnutrition Nutrition 0.000 description 4
- 230000001071 malnutrition Effects 0.000 description 4
- 208000015380 nutritional deficiency disease Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 235000014659 low sodium diet Nutrition 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000021023 sodium intake Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000002723 Atrial Natriuretic Factor Human genes 0.000 description 1
- 101800001288 Atrial natriuretic factor Proteins 0.000 description 1
- 238000010989 Bland-Altman Methods 0.000 description 1
- 101800000407 Brain natriuretic peptide 32 Proteins 0.000 description 1
- 102400000667 Brain natriuretic peptide 32 Human genes 0.000 description 1
- 101800002247 Brain natriuretic peptide 45 Proteins 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010013012 Dilatation ventricular Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000037849 arterial hypertension Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000011871 bio-impedance analysis Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical class C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 description 1
- 238000011281 clinical therapy Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 230000036723 left ventricular dilatation Effects 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4875—Hydration status, fluid retention of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6828—Leg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/061—Measuring instruments not otherwise provided for for measuring dimensions, e.g. length
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- External Artificial Organs (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39354410P | 2010-10-15 | 2010-10-15 | |
| US61/393,544 | 2010-10-15 | ||
| PCT/US2011/055916 WO2012051261A2 (en) | 2010-10-15 | 2011-10-12 | Dry weight predictor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016165488A Division JP6280176B2 (ja) | 2010-10-15 | 2016-08-26 | ドライウエイト予測方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542782A JP2013542782A (ja) | 2013-11-28 |
| JP2013542782A5 JP2013542782A5 (enExample) | 2014-11-27 |
| JP6034292B2 true JP6034292B2 (ja) | 2016-11-30 |
Family
ID=45938942
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013533964A Expired - Fee Related JP6034292B2 (ja) | 2010-10-15 | 2011-10-12 | ドライウエイト予測装置 |
| JP2016165488A Expired - Fee Related JP6280176B2 (ja) | 2010-10-15 | 2016-08-26 | ドライウエイト予測方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016165488A Expired - Fee Related JP6280176B2 (ja) | 2010-10-15 | 2016-08-26 | ドライウエイト予測方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10820827B2 (enExample) |
| EP (1) | EP2627248A4 (enExample) |
| JP (2) | JP6034292B2 (enExample) |
| CN (1) | CN103209639B (enExample) |
| AU (1) | AU2011316667B2 (enExample) |
| CA (1) | CA2814655C (enExample) |
| MX (1) | MX337523B (enExample) |
| WO (1) | WO2012051261A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014137363A1 (en) * | 2013-03-08 | 2014-09-12 | Fresenius Medical Care Holdings, Inc. | Bioimpedance circumference measurement |
| US10362968B2 (en) | 2010-10-15 | 2019-07-30 | Fresenius Medical Care Holdings, Inc. | Bioimpedance circumference measurement |
| US9861293B2 (en) | 2011-04-28 | 2018-01-09 | Myolex Inc. | Sensors, including disposable sensors, for measuring tissue |
| WO2012149471A2 (en) * | 2011-04-28 | 2012-11-01 | Convergence Medical Devices | Devices and methods for evaluating tissue |
| DE102011118998A1 (de) * | 2011-11-14 | 2013-05-16 | Seca Ag | Verfahren und Vorrichtung zur Ermittlung des Körpergewichtes einer Person |
| EP2854633A1 (en) * | 2012-06-05 | 2015-04-08 | Koninklijke Philips N.V. | Method and apparatus for estimating the fluid content of a part of the body of a subject |
| EP3111837B1 (en) * | 2014-02-25 | 2020-10-28 | School Juridical Person The Kitasato Institute | Image generating device and image generating method |
| US11395628B2 (en) * | 2017-02-16 | 2022-07-26 | Samsung Electronics Co., Ltd. | Method of providing service based on biometric information and wearable electronic device |
| JP7276155B2 (ja) * | 2018-01-10 | 2023-05-18 | ニプロ株式会社 | 細胞外液量算出装置及び細胞外液量算出方法 |
| WO2020020801A1 (en) * | 2018-07-27 | 2020-01-30 | Biotronik Se & Co. Kg | Device; system and method for determining fluid accumulation in the lower extremities of a patient |
| DE102019134538A1 (de) * | 2019-12-16 | 2021-06-17 | KOB GmbH | Vorrichtung zur Überwachung der Kompressionstherapie eines Kompressionsmittels |
| CN112951419B (zh) * | 2020-11-11 | 2021-09-14 | 复旦大学附属华山医院 | 血液透析干体重智能评估装置 |
| CN115590493A (zh) * | 2021-07-07 | 2023-01-13 | 华为技术有限公司(Cn) | 一种可穿戴设备及生理参数测量方法 |
| WO2025178351A1 (ko) * | 2024-02-20 | 2025-08-28 | 주식회사 인바디 | 건체중 범위를 결정하는 전자 장치 및 그 동작 방법 |
| CN120514357B (zh) * | 2025-07-24 | 2025-10-21 | 上海市第六人民医院金山分院(上海健康医学院附属金山区中心医院、上海市金山区中心医院) | 干体重测量装置及基于干体重确定脱水量的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536258A (en) * | 1967-10-06 | 1970-10-27 | Industrial Nucleonics Corp | Moisture measuring apparatus |
| US7801598B2 (en) * | 2000-08-14 | 2010-09-21 | Fresenius Medical Care Holdings, Inc. | Device and method for the determination of dry weight by continuous measurement of resistance and calculation of circumference in a body segment using segmental bioimpedance analysis |
| US7228170B2 (en) * | 2000-08-14 | 2007-06-05 | Renal Research Institute, Llc | Device and method for monitoring and controlling physiologic parameters of a dialysis patient using segmental bioimpedance |
| US6615077B1 (en) | 2000-08-14 | 2003-09-02 | Renal Research Institute, Llc | Device and method for monitoring and controlling physiologic parameters of a dialysis patient using segmental bioimpedence |
| ES2187422T3 (es) * | 2000-11-06 | 2003-06-16 | Fresenius Medical Care De Gmbh | Metodo y dispositivo para determinar el peso en seco de un paciente con fracaso renal. |
| ES2287174T3 (es) | 2001-12-12 | 2007-12-16 | Fresenius Medical Care Deutschland Gmbh | Determinacion del estado de hidratacion de un paciente. |
| EP1662993B1 (en) | 2003-09-12 | 2016-11-02 | Renal Research Institute, LLC | Bioimpedance methods and apparatus |
| ATE519424T1 (de) * | 2004-06-29 | 2011-08-15 | Fresenius Medical Care De Gmbh | Verfahren und vorrichtung zur bestimmung der hydrierung und/oder des ernährungszustands eines patienten |
| WO2006042218A2 (en) * | 2004-10-07 | 2006-04-20 | Levin Nathan W | Device and method for the determination of dry weight by continuous measurement of resistance and calculation of circumference in a body segment using segmental bioimpedance analysis |
| WO2009029899A1 (en) * | 2007-09-01 | 2009-03-05 | Sang Hoon Woo | Controlling body fluid condition using diuretics |
-
2011
- 2011-10-12 CN CN201180049716.5A patent/CN103209639B/zh not_active Expired - Fee Related
- 2011-10-12 JP JP2013533964A patent/JP6034292B2/ja not_active Expired - Fee Related
- 2011-10-12 EP EP11833309.5A patent/EP2627248A4/en not_active Withdrawn
- 2011-10-12 AU AU2011316667A patent/AU2011316667B2/en not_active Ceased
- 2011-10-12 WO PCT/US2011/055916 patent/WO2012051261A2/en not_active Ceased
- 2011-10-12 MX MX2013004153A patent/MX337523B/es active IP Right Grant
- 2011-10-12 CA CA2814655A patent/CA2814655C/en not_active Expired - Fee Related
- 2011-10-12 US US13/879,220 patent/US10820827B2/en not_active Expired - Fee Related
-
2016
- 2016-08-26 JP JP2016165488A patent/JP6280176B2/ja not_active Expired - Fee Related
-
2020
- 2020-09-25 US US17/032,443 patent/US20210015397A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2814655C (en) | 2021-07-13 |
| EP2627248A4 (en) | 2017-11-29 |
| CN103209639A (zh) | 2013-07-17 |
| WO2012051261A3 (en) | 2012-06-21 |
| JP2016193375A (ja) | 2016-11-17 |
| CA2814655A1 (en) | 2012-04-19 |
| CN103209639B (zh) | 2016-05-04 |
| US20210015397A1 (en) | 2021-01-21 |
| US10820827B2 (en) | 2020-11-03 |
| AU2011316667A1 (en) | 2013-05-02 |
| WO2012051261A2 (en) | 2012-04-19 |
| MX2013004153A (es) | 2013-05-20 |
| US20130197389A1 (en) | 2013-08-01 |
| JP2013542782A (ja) | 2013-11-28 |
| EP2627248A2 (en) | 2013-08-21 |
| AU2011316667B2 (en) | 2015-01-22 |
| MX337523B (es) | 2016-03-09 |
| JP6280176B2 (ja) | 2018-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6280176B2 (ja) | ドライウエイト予測方法 | |
| EP2874540B1 (en) | Calibration of a body parameter for monitoring dialysis | |
| Lukaski et al. | Bioelectrical impedance vector analysis for assessment of hydration in physiological states and clinical conditions | |
| CN101102718B (zh) | 确定病人水合和/或营养状况的方法和装置 | |
| Woodrow et al. | Article commentary: application of bioelectrical impedance to clinical assessment of body composition in peritoneal dialysis | |
| JP6384667B2 (ja) | 患者のドライウェイトを推定する方法 | |
| US11234609B2 (en) | Techniques for determining fluid volumes using bioimpedance information | |
| JP2022520750A (ja) | 筋肉関連の疾患を評価する方法 | |
| Baldwin et al. | Body composition analysis in critically ill survivors: a comparison of bioelectrical impedance spectroscopy devices | |
| Zhu et al. | Estimation of body composition and normal fluid status using a calf bioimpedance technique | |
| Choi et al. | Consistency of the estimated target weights and ECW/TBW using BIA after hemodialysis in patients between standing and lying-down positions | |
| Miles et al. | Peripheral intravenous volume analysis (PIVA) for quantitating volume overload in patients hospitalized with acute decompensated heart failure—a pilot study | |
| Levin et al. | Use of segmental multifrequency bioimpedance spectroscopy in hemodialysis | |
| Chi et al. | Using bioelectrical impedance vector analysis method estimate the hydration state during hemodialysis | |
| Zhu et al. | Evaluation of one year of frequent dialysis on fluid load and body composition using calf bioimpedance technique | |
| Yashiro et al. | The evaluation of filtration coefficients of microvasculature for the assessment of fluid status in hemodialysis patients | |
| Aldobali et al. | Bioelectrical impedance analysis body composition estimation of fat mass percentage in people with spinal cord injury | |
| Kalra et al. | An international matched cohort study of the contribution of metabolic impairments to subclinical atherosclerosis in United Kingdom and Jamaican African-Caribbeans | |
| Tiba et al. | Dynamic limb bioimpedance and inferior vena cava ultrasound in patients undergoing hemodialysis | |
| Aldobali et al. | Validation and predicting total body water in people with spinal cord injury using bioelectrical impedance analysis | |
| EP1809354B1 (en) | Device and method for the determination of dry weight by continuous measurement of resistance and calculation of circumference in a body segment using segmental bioimpedance analysis | |
| Skroński et al. | Assessment of changes in the body composition in patients qualified for the operational treatment of the primary and metastatic liver tumors with the use of bioelectric impedance | |
| Shin et al. | Optimizing hemodialysis management using bioelectrical impedance analysis: emphasizing the significance of the phase angle | |
| Underwood | Bioimpedance Spectroscopy for the Health Care Professional | |
| Keane | Characterising fluid status, distribution and dynamics in haemodialysis patients to improve fluid management strategies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141010 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20141010 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150724 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150825 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151125 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160426 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160826 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160826 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20160902 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160927 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161027 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6034292 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |